Literature DB >> 19525382

Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction.

Alexandru B Chicos1, Prince J Kannankeril, Alan H Kadish, Jeffrey J Goldberger.   

Abstract

Depressed parasympathetic activity has been proposed to be associated with an increased risk of sudden death. Parasympathetic effects (PE) on cardiac electrophysiology during exercise and recovery have not been studied in patients with left ventricular dysfunction. We performed noninvasive electrophysiological studies (NI-EPS) and characterized the electrophysiological properties of the sinus node, atrioventricular (AV) node, and ventricle in subjects with depressed left ventricular ejection fraction and dual-chamber defibrillators. NI-EPS were performed during rest, exercise, and recovery at baseline and after parasympathetic blockade with atropine to assess PE (the difference between parameter values in the 2 conditions). Ten subjects (9 men: age, 60 +/- 9 yr; and left ventricular ejection fraction, 29 +/- 8%) completed the study. All NI-EPS parameters decreased during exercise and trended toward rest values during recovery. PE at rest, during exercise, and during recovery, respectively, were on sinus cycle length, 320 +/- 71 (P = 0.0001), 105 +/- 60 (P = 0.0003), and 155 +/- 82 ms (P = 0.0002); on AV block cycle length, 137 +/- 136 (P = 0.09), 37 +/- 19 (P = 0.002), and 61 +/- 39 ms (P = 0.006); on AV interval, 58 +/- 32 (P = 0.035), 22 +/- 13 (P = 0.002), and 36 +/- 20 ms (P = 0.001); on ventricular effective refractory period, 15.8 +/- 11.3 (P = 0.02), 4.7 +/- 15.2 (P = 0.38), and 6.8 +/- 15.5 ms (P = 0.20); and on QT interval, 13 +/- 12 (P = 0.13), 3 +/- 17 (P = 0.6), and 20 +/- 23 (P = 0.04). In conclusion, we describe for the first time the changes in cardiac electrophysiology and PE during rest, exercise, and recovery in subjects with left ventricular dysfunction. PEs are preserved in these patients. Thus the role of autonomic changes in the pathophysiology of sudden death requires further exploration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525382      PMCID: PMC2724198          DOI: 10.1152/ajpheart.00193.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Atrial and ventricular refractoriness in paced patients; circadian variation and its relationship to autonomic nervous system activity.

Authors:  E N Simantirakis; S I Chrysostomakis; M E Marketou; G E Kochiadakis; K E Vardakis; H E Mavrakis; P Vardas
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

Review 2.  Beta-adrenergic blockade for survivors of acute myocardial infarction.

Authors:  W H Frishman; C D Furberg; W T Friedewald
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

3.  Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in humans. Evidence supporting a direct cholinergic action on ventricular muscle refractoriness.

Authors:  E N Prystowsky; W M Jackman; R L Rinkenberger; J J Heger; D P Zipes
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

4.  Human ventricular refractoriness. Effects of cycle length, pacing site and atropine.

Authors:  S B Guss; J A Kastor; M E Josephson; D L Schare
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

5.  Enhanced predictive power of quantitative TWA during routine exercise testing in the Finnish Cardiovascular Study.

Authors:  Mikko Minkkinen; Mika Kähönen; Jari Viik; Kjell Nikus; Terho Lehtimäki; Rami Lehtinen; Tiit Kööbi; Väinö Turjanmaa; Willi Kaiser; Richard L Verrier; Tuomo Nieminen
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-11

6.  Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era.

Authors:  Heikki V Huikuri; Jari M Tapanainen; Kai Lindgren; Pekka Raatikainen; Timo H Mäkikallio; K E Juhani Airaksinen; Robert J Myerburg
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

9.  Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study.

Authors:  G Sanz; A Castañer; A Betriu; J Magriña; E Roig; S Coll; J C Paré; F Navarro-López
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

10.  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

Authors: 
Journal:  JAMA       Date:  1982-03-26       Impact factor: 56.272

View more
  4 in total

1.  QT-RR hysteresis is caused by differential autonomic states during exercise and recovery.

Authors:  Daniel J Pelchovitz; Jason Ng; Alexandru B Chicos; Daniel W Bergner; Jeffrey J Goldberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  Persistent sympathoexcitation long after submaximal exercise in subjects with and without coronary artery disease.

Authors:  Norman C Wang; Alexandru Chicos; Smriti Banthia; Daniel W Bergner; Marc K Lahiri; Jason Ng; Haris Subacius; Alan H Kadish; Jeffrey J Goldberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

3.  Recovery of heart rate variability and ventricular repolarization indices following exercise.

Authors:  Marc K Lahiri; Alexandru Chicos; Dan Bergner; Jason Ng; Smirti Banthia; Norman C Wang; Haris Subačius; Alan H Kadish; Jeffrey J Goldberger
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

4.  Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitus.

Authors:  Jeffrey J Goldberger; Daniel J Pelchovitz; Jason Ng; Haris Subacius; Alexandru B Chicos; Smriti Banthia; Mark Molitch; Ronald B Goldberg
Journal:  Cardiol J       Date:  2020-05-07       Impact factor: 2.737

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.